|
Originally published In Press as doi:10.1074/jbc.M201145200 on June 26, 2002
J. Biol. Chem., Vol. 277, Issue 36, 32527-32537, September 6, 2002
RNA Polymerase II Transcription Complexes May Become Arrested If
the Nascent RNA Is Shortened to Less than 50 Nucleotides*
Andrea
Újvári,
Mahadeb
Pal, and
Donal S.
Luse
From the Department of Molecular Biology, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195
Received for publication, February 4, 2002, and in revised form, June 10, 2002
 |
ABSTRACT |
A significant fraction of RNA polymerase II
transcription complexes become arrested when halted within a particular
initially transcribed region after the synthesis of 23-32-nucleotide
RNAs. If polymerases are halted within the same sequence at a
promoter-distal location, they remain elongation-competent. However,
when the RNAs within these promoter-distal complexes are truncated to
between 21 and 48 nucleotides, many of the polymerases become arrested. The degree of the arrest correlates very well with the length of the
RNA in both the promoter-proximal and -distal complexes. This effect is
also observed when comparing promoter-proximal and promoter-distal
complexes halted over a completely different sequence. The unusual
propensity of many promoter-proximal RNA polymerase II complexes to
arrest may therefore be recreated in promoter-distal complexes simply
by shortening the nascent RNA. Thus, the transition to full elongation
competence by RNA polymerase II is dependent on the synthesis of about
50 nt of RNA, and this transition is reversible. We also found that
arrest is facilitated in promoter-distal complexes by the hybridization
of oligonucleotides to the transcript between 30 and 45 bases upstream
of the 3'-end.
 |
INTRODUCTION |
There is increasing evidence for eukaryotic gene regulation during
the process of transcript elongation (reviewed in Ref. 1). It is thus
important to understand in detail the elements that affect the
efficiency of elongation by RNA polymerase II transcription complexes.
Both biochemical (reviewed in Ref. 2) and structural studies of
prokaryotic and eukaryotic RNA polymerases support a particular model
of the transcript elongation complex (3-7). According to this model,
ternary complexes are stabilized primarily by the presence of an
8-9-bp RNA-DNA hybrid just upstream of the catalytic center of the RNA
polymerase and by a domain of the polymerase that serves as a sliding
clamp, encircling the DNA just downstream of the active site and
preventing dissociation of the template from the complex.
This model explains certain examples of sequence-specific loss of
elongation competence, or arrest, by multisubunit RNA polymerases. For
example, RNA polymerase II arrests primarily at the boldfaced Ts while
traversing the TIa sequence (nontemplate strand)
TTTTTTTCCCTTTTTT from the histone H3.3 gene (8). Complexes
with U-rich 3'-ends contain the weakest possible RNA-DNA hybrid (U:dA).
In response to this situation, the polymerase can translocate upstream,
carrying the transcription bubble to a location where a more stable
RNA-DNA hybrid forms. Indeed, an upstream translocated footprint was
reported for polymerases arrested at the histone H3.3 TIa
site (9, 10). Upstream translocation removes the 3'-end of the RNA from
the active site and thus prevents transcription from continuing.
Arrested complexes can be restarted by cleavage of the transcript such that the 3' RNA end is again aligned with the enzyme catalytic center.
This cleavage is catalyzed by the active site of the polymerase and is
highly stimulated by the transcription factor SII for RNA polymerase II
and by GreA and GreB in the case of Escherichia coli RNA
polymerase (11-15).
Kerppola and Kane (8) have shown that although arrest at the histone
H3.3 TIa site occurs within the upstream run of nontemplate strand Ts, the second, downstream T-run is also required for efficient arrest. The RNA polymerase must therefore recognize downstream DNA
sequences as arrest signals at the DNA level. Consistent with this,
upstream translocation of RNA polymerases stalled on different DNA
templates was shown to be affected by DNA sequences downstream of the
point of stalling (10).
The model just discussed has provided a major advance in our
understanding of transcript elongation and arrest at promoter-distal DNA sites. However, the model fails to explain the properties of newly
initiated transcription complexes. Temporary stalling of RNA polymerase
II complexes in the region of +20 to +25 at one particular promoter
leaves complexes strongly upstream translocated but nevertheless fully
or predominantly elongation-competent (10, 16). Similar observations
were made by Nudler et al. (17) and Komissarova and Kashlev
(18), who have reported that E. coli RNA polymerase
promoter-proximal complexes also translocate upstream. These results
are significant, since in vivo pausing of RNA polymerase II
in the same region, after the synthesis of a
20-40-nt1 transcript, has
been shown to be important for the regulation of expression of many
genes, including hsp70, c-myc, and
c-fos (19-24).
Luse and Samkurashvili (25) argued that upstream
translocation of promoter-proximal RNA polymerase II is not driven by
weak RNA-DNA hybrids or downstream DNA elements, since initially
transcribed sequences within which upstream translocation takes place
present no barrier to polymerase translocation at promoter-distal
locations. Complexes with transcripts longer than about 45 nt no longer
showed upstream translocation (26), so transcript length seemed to be
an important determinant of lateral stability on the template. However,
the earlier study could not separate effects based simply on transcript
length from those that also depended upon proximity to promoter sequences.
We have now investigated directly the role of transcript length on the
elongation competence of transcription complexes, independent of the
presence of the promoter. Through the use of carefully controlled
transcript cleavage procedures, we have prepared matched sets of
transcription complexes with identical transcript length and nearly
identical transcript sequence at promoter-proximal and promoter-distal
locations. The corresponding complexes display very similar levels of
transcriptional arrest. Thus, the nascent RNA itself, well upstream
(i.e. 20-50 nt) of the 3'-end, facilitates continued
transcript elongation by the ternary complex.
 |
MATERIALS AND METHODS |
Reagents--
FPLC-purified NTPs and RNase H (catalog no.
27-0894-02) were purchased from Amersham Biosciences;
32P-labeled NTPs were from PerkinElmer Life
Sciences; Bio-Gel A1.5m was from Bio-Rad; Deep Vent DNA
polymerase was from New England Biolabs; and ribonuclease inhibitor and
restriction endonucleases were from Invitrogen. Recombinant human
elongation factor SII was purified as described previously (27).
Chimeric 2'-O-methyl-RNA/DNA oligonucleotides, synthesized
by Oligos Etc., had the following sequences: chimera 1, 5'-dCdGdCdGGmGmUmGmCmCm-3'; chimera 2, 5'-dCdCdTdGCmCmGmCmGmGm-3'; chimera 3, 5'-dGdCdGdTCmUmCmGmCmUm-3';
chimera 4, 5'-dCdCdCdGGmGmUmUmUmAm-3'; chimera 5, 5'-dGdCdCdTCmGmUmCmGmCmCm-3'.
Plasmids--
The promoters in all plasmids are based on the
adenovirus major late promoter. The construction of pML20-23 and the
series of pML20-23like plasmids was described previously (16). Plasmid pML20-23like3, which was used in this study, has the following sequence on the nontemplate strand starting at position +1:
ACAGGAAGAGGAAGAAGCAGGCCT. The last six bases form a recognition site
for the restriction enzyme StuI; downstream of the
StuI site, the pML20-23like plasmids have the same sequence
as the pML20-42 construct (26). The sequence of pML20-23like3
downstream of position +2 is identical to the sequence of pML20-23
starting with position +130 (see Fig. 1). pML20-55 M was constructed
by replacing the fragment between StuI (+25) and
XhoI (+39) on pML20-42 with a 66-bp synthetic fragment of
the following sequence (nontemplate strand):
5'-CCTCGGCTGCGTGCGCCGTCGGGCCCGGCACTCT- CTTCCCCTTCTCTTTAAAGGCCTCGGCCGCGC-3'.
Template Preparation--
Plasmid DNA was either purified by
cesium chloride centrifugation or by a Qiagen Maxi Plasmid kit. Closed
circular DNA was used as the DNA template in experiments with the
plasmid pML20-23. In the case of the pML20-23like3 plasmid, the
template was produced by PCR that amplifies a 190-bp fragment with the
transcription start site 96 bp from the 5'-end. DNA was purified with
the Concert Rapid PCR purification system (Marligen Bioscience) and
then cut downstream of the promoter with the restriction enzyme
HindIII to yield a 178-bp template. The DNA was then
phenol/chloroform-extracted and ethanol-precipitated. Bead-attached
templates for the experiment in Fig. 8 were made by PCR using
the pML20-55 M plasmid and the methods described in Ref.
16.
Assembly and Purification of Ternary Transcription
Complexes--
Preinitiation complexes were formed in a reaction
containing 18 µg/ml circular plasmid or 10 µg/ml PCR
fragment with HeLa cell nuclear extract and were purified through a
Bio-Gel A1.5m column to remove contaminating NTPs as described (10).
Ternary complexes on the template pML20-23 containing 151 nt or longer RNAs were synthesized in multiple steps. Complexes stalled at position
+20 were generated at 30 °C for 5 min with 1 mM ApC as the initiating dinucleotide; a 20 µM concentration each
of UTP, CTP, and GTP; and 50 µM dATP as the energy
source. After the addition of the detergent sarkosyl to 1%, complexes
were gel-filtered (sarkosyl rinsing; see Ref. 10). Sarkosyl-rinsed U20
complexes were elongated through a U-free cassette to make C151
complexes. If C151 complexes were analyzed directly, they were
generated from U20 with 600 µM ATP, 100 µM
CTP, 9 µM GTP, and 1 µM
[ -32P]GTP for 10 min at 37 °C, followed by the
addition of nonlabeled GTP to 600 µM with further
incubation for 5 min at 37 °C. If complexes containing RNAs longer
than 151 nt were required, C151 was synthesized without radiolabel for
10 min at 37 °C. The C151 complexes were gel-filtered to remove
NTPs. U154, G157, or A160 were then generated by the addition of 1.5 µM [ -32P]UTP for 5 min at 37 °C
followed by 50 µM nonlabeled UTP; UTP and GTP; or UTP,
GTP, and ATP for 5 min at 37 °C (see Fig. 1 for the sequences).
Ternary complexes (G17) stalled at position +17 on the pML20-23like3
template were synthesized by incubating preinitiation complex with 1 mM ApC, 20 µM ATP, 50 µM dATP,
and 1 µM [ -32P]GTP for 5 min at
30 °C, followed by incubation for 5 min at 30 °C with nonlabeled
20 µM GTP and sarkosyl rinsing. Similarly, C23 was made from
preinitiation complex with 1 mM ApC, 20 µM
each ATP and GTP, 50 µM dATP, and 1 µM
[ -32P]CTP for 5 min at 30 °C followed by the
addition of 20 µM nonlabeled CTP, 5 min of further
incubation at 30 °C, and sarkosyl rinsing. G17 complexes were
elongated to C18 and C23 complexes to U26, G29, or A32 by the addition
of the appropriate NTPs at 50 µM and incubation for 5 min
at 25 °C.
The experiment in Fig. 8 used bead-attached templates generated by PCR
from the pML20-55 M template. Primers for generating the PCR
fragments, preparation of the bead attached templates, and assembly of
preinitiation complexes on these templates were as described (16).
Complexes were advanced to the desired positions as given in the Fig. 8 legend.
Site-specific Cleavage of RNA and Chase of Ternary
Complexes--
2'-O-methyl-RNA/DNA chimeras were added to
ternary complexes stalled on pML20-23 at a final concentration of
0.1-10 µM and were incubated in the presence of a final
concentration of 0.03 units/µl RNase H and 0.05 units/µl
ribonuclease inhibitor for 10 min at 37 °C. This yields the
site-specific cleavage of the RNA in the complex at the 5'-end of the
chimera (28, 29). We believe that the faint bands that were
occasionally seen above the main products (see, for example,
lanes 2, 6, and 10 of Fig. 2) are not due to variations in the location of RNase H digestion but
rather to low levels of read-through RNA in the original transcription reaction (note, for example, the presence of 152-mers in the C151 preparation in Ref. 10). This explanation is consistent with our
results with U154 complexes, which were generated from C151 with low
levels of UTP and which do not appear to have any read-through products. In that case, RNase H cleavage with the chimeric
oligonucleotides gave essentially a single band (see Fig. 3).
Transcript truncation for the experiment in Fig. 8 was performed using
RNase T1 digestion as described in the legend to Fig. 8.
Complexes treated with RNase H were tested for transcriptional
competence by the addition of 50 µM NTPs at 37 °C as
described in detail in the figure legends. No chimeras or RNase H were
added to the complexes synthesized on pML20-23like3, but these were also incubated at 37 °C for 10 min to mimic conditions of the RNase
H cleavage experiment. These complexes were then immediately chased by further incubation with 50 µM NTPs at 37 °C
for 5 min. When indicated, a final concentration of 18 µg/ml
of SII (or 29 µg/ml, for the experiment in Fig. 8) was
included in the chase reactions.
It should be noted that C17 and G18 complexes showed significant
transcript truncation, in the absence of added SII, during a 5-min
incubation at 25 °C (compare lanes 2 and
3 with lane 1 in Fig. 4). Truncation
was more pronounced during mock-chase incubations at 37 °C (compare
lanes 2 and 3 with lanes
4 and 7). This transcript cleavage involved RNA
polymerase, since it was completely inhibited by -amanitin (data not
shown) and was essentially confined to the C17 and G18 complexes. We
did not observe breakdown with early elongation complexes walked to
position +23 or later (Fig. 4), nor did we see this effect with
promoter-distal complexes whose transcripts had been trimmed with RNase
H to 18 nt or any other length (Figs. 2 and 3). We believe that the
source of the cleavage is a very low level of SII from the nuclear
extract that was not removed by the sakosyl rinsing, since the addition
of sarkosyl to the C17 or G18 complexes prevented RNA breakdown without
inhibiting the elongation of the transcripts upon chase (data not
shown). However, we cannot exclude the possibility that very early
elongation complexes differ from later complexes in a way that renders
their transcripts exceptionally labile to cleavage. If residual SII did
remain in the promoter-proximal C17 and G18 complexes (Fig. 4), this
cannot explain their very low level of arrest relative to, for example,
C23 promoter-proximal complexes, since promoter-distal C18 complexes
generated by RNase H cleavage, which show no RNA breakdown upon
incubation, are also fully elongation-competent (Fig. 2).
It is important to note that after the sarkosyl washing step,
transcript initiation factors are removed (see Refs. 26 and 30). Thus,
once transcript cleavage was performed with oligonucleotides and RNase
H, there was no need to remove these components during subsequent chase
reactions, since the transcript segments targeted by the
oligonucleotides could not be regenerated.
All transcription reactions were phenol/chloroform-extracted and
(except for the Fig. 7 experiment) ethanol-precipitated. The reactions
in Fig. 7 were concentrated by lyophilization and loaded directly to
avoid loss of the short transcript cleavage products. Samples were
resolved on denaturing polyacrylamide (19:1 ratio of acrylamide to
bisacrylamide) gels with the following percentages of acrylamide: Fig.
6, 6%; Figs. 2-4, 13%; Figs. 7 and 8, 20%. Radioactivity was
visualized on a PhosphorImager, and quantitation was done with the
program ImageQuant (Amersham Biosciences).
 |
RESULTS |
Samkurashvili and Luse (10) reported on the exonuclease III
footprints of several RNA polymerase II complexes stalled far downstream from the adenovirus major late promoter. That study employed
a template, called pML20-23, which was constructed in such a way that
RNA polymerase could be advanced in only two steps to position +151.
The sequence TTTGGGAAACCC on the nontemplate strand immediately
downstream of position +151 allowed walking of the polymerase from C151
to U154, G157, or A160 by incubating with a subset of NTPs (see Fig.
1). All of the complexes stalled from
+151 to +160 were found to be fully active in chase reactions (only
about 5-10% failed to restart transcription), and their exonuclease
III footprints advanced synchronously along the template with the
polymerase active site.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 1.
RNA sequences used in this study. The
transcript of the pML20-23 template from position +97 to +163 is shown
in the upper panel. The positions at which three
chimeric 2'-O-methyl-RNA/DNA oligonucleotides anneal to this
RNA are shown. The dotted lines indicate the
expected 5'-ends that should be generated when hybrids of these
oligonucleotides with C151-A160 RNAs are treated with RNase H. The
lengths and sequences of the RNAs that should remain in ternary complex
after cleavage are also shown. The lower panel
shows the sequences of 17-32-nt transcripts generated on the
pML20-23like3 plasmid by a combination of limited nucleotide additions
and gel filtration. Sequences in the upper and
lower panels are aligned to show identical
sequence regions. Note in particular that the sequences of C23, U26,
G29, and A32 transcripts made by direct transcription (lower
panel) or transcript cleavage (upper
panel) are identical except for the 5' nucleotide.
|
|
To study the same DNA sequence in a promoter-proximal context, the
region downstream of position +130 on plasmid pML20-23 was moved to
the beginning of the initially transcribed region of the adenovirus
major late promoter, creating the pML20-23like series of plasmids
(16). In this case, the TTTGGGAAACCC sequence begins only 24 bases
downstream of +1 (see Fig. 1). Surprisingly, the RNA polymerase II
complexes corresponding to the +151 to +160 complexes on pML20-23,
namely C23, U26, G29, and A32, were all found to be severely arrested
on this template (16) (also see Fig. 4). To determine the basis for the
difference in elongation competence of these complexes, we cleaved the
RNAs in the promoter-distal complexes so that they matched, in length
and sequence, the transcripts in the promoter-proximal complexes.
Transcript Truncation in Promoter-distal Complexes--
In our
initial pilot experiments, we used RNase A to cut the transcripts in
C151 complexes made on the pML20-23 plasmid. After the RNase A
digestion, a prominent 21-nt-long RNA remained in the ternary
complexes. We found that these 21-mer complexes were predominantly
arrested (data not shown). Encouraged by this observation, we employed
a procedure that permits sequence-specific cleavage of transcripts in
ternary transcription complexes. This involved the use of RNase H in
combination with different 2'-O-methyl-RNA/DNA chimeric
oligonucleotides. When such chimeras containing four DNA
residues at the 5'-end are annealed to RNA and the hybrids are treated with RNase H, cleavage has been shown to occur
exclusively at the 5'-end of the chimera (28) (see
"Materials and Methods").
Fig. 2 shows the results of an experiment
in which chimeras 1-3 (Fig. 1) were separately annealed to
body-labeled RNA in the C151 complex (uncut RNA is shown in
lane 1). The conditions of the RNase H digestion
were optimized so that more than 90% of the input RNA was cut in 10 min at 37 °C. We also confirmed that this incubation without the
addition of RNase H did not deactivate the C151 complexes (see Fig.
6A, lanes 1 and 2).
Digestion with RNase H yielded primarily RNAs that were 18, 23, and 45 nt long (lanes 2-5, 6-9, and
10-13, respectively), with a faint additional band 1 nt
longer (see "Materials and Methods").

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 2.
Truncation of the transcript in C151
complexes can lead to arrest. Complex C151 was synthesized on
plasmid pML20-23 (lane 1) and the body-labeled
RNA was cleaved by RNase H after annealing the indicated chimeric
oligonucleotide as described under "Materials and Methods."
Chimeras 1 and 2 were used at a concentration of 3 µM. To
eliminate hybridization of chimera 3 to alternative sites, it was added
only to a final concentration of 0.1 µM. Ternary
complexes containing 18-nt (lanes 2-5), 23-nt
(lanes 6-9), and 45-nt (lanes
10-13) RNAs were initially chased with 50 µM
of the indicated NTPs for 5 min at 37 °C. In lanes
4, 8, and 12, an additional 5-min
chase with GTP at 50 µM was performed at 37 °C; in all
other lanes (except lane 1), the
initial chase incubation was simply continued for an additional 5 min.
The percentages of the complexes that arrested were calculated by
comparing the initial complex to the fraction that remained after
single nucleotide chase. For example, 11% of the 18-mer in
lane 2 remained in lane
3.
|
|
After cleavage, the complexes were immediately chased with 50 µM UTP or UTP and GTP at 37 °C for 5 min. At the end
of the first chase, a final 50 µM GTP was added to
lanes 4, 8, and 12, and all
tubes were incubated for an additional 5 min. The amount of arrest was
calculated as the percentage of the complex that could not be elongated
in the chase reaction. For example, 11% of the C18 band remained in
lane 3 as compared with C18 in lane 2. We consider complex C18 fully active, since about the
same fraction (14%) of its parent complex, C151, cannot be chased
after a 10-min incubation at 37 °C without RNase H (Fig.
6A). In contrast to the C18 complex, complexes C23 and C45
were found to be arrested (73 and 53%, respectively) in this
experiment. If the elongation factor SII was included in the chase
reactions, nearly all (>95%) of the complexes could be elongated
(data not shown; see Fig. 4).
The same experiment was repeated with complex U154 (Fig.
3). In this case, the RNA was
3'-end-labeled; therefore, only the 3' segment is detectable after the
cleavage reaction. Note the disappearance of the 5' cleavage products
from the top of the gel. We observed that the U21, U26, and
U48 complexes were 56, 89, and 35% arrested, respectively. These
results show that the promoter-distal complexes that are fully
elongation-competent can be converted to complexes that are easily
arrested, like their promoter-proximal counterparts.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 3.
Truncation of the transcript in U154
complexes can lead to arrest. Complex U154 was synthesized on
plasmid pML20-23 (lane 1) with only the last 3 nt labeled. RNA was cleaved by RNase H after annealing the indicated
chimeric oligonucleotides as described under "Materials and
Methods." Oligonucleotides were used at the same concentrations as in
the experiment in Fig. 2. Transcripts remaining in complex were
initially chased with a 50 µM concentration of the
indicated NTPs for 5 min at 37 °C. In lanes 4,
8, and 12, an additional 5-min chase with ATP at
50 µM was performed at 37 °C; in all other lanes
(except lane 1), the initial chase incubation was
simply continued for an additional 5 min. The percentages of the
complexes that arrested were calculated by comparing the initial
complex to the fraction that remained after single nucleotide chase.
For example, 56% of the 21-mer in lane 2 remained in lane 3.
|
|
During these experiments, we noticed that the extent of arrest for a
given complex was clearly dependent on the incubation time. For
example, if C18 was chased in the presence of both UTP and GTP (Fig. 2,
lane 5), most complexes successfully elongated to
G24. If only UTP was included in the reaction mixture during the first
5 min, all complexes advanced to C21, but only a small fraction of them
could be chased further to G24 by the addition of GTP in a second 5-min
incubation (lane 4). Thus, the half-life of the
transcriptionally active form of the C21 complex is less than 5 min.
Similar results were seen with complexes U26 and U48 in Fig. 2 (compare
lane 8 with lane 9 and
lane 12 with lane 13) and
with complexes U21 and U26 in Fig. 3 (compare lane
4 with lane 5 and lane
8 with lane 9).
Complexes Containing RNAs Longer than About 50 nt Are Fully
Active--
About 35% of the initial U48 complex failed to advance to
G51 in a 5-min chase (lanes 10 and 11 of Fig. 3). However, when the G51 complexes were chased in a second
5-min reaction, all of them extended their RNAs to A54 (lane
12). To test longer RNA sequences, we performed an
experiment in which a 2'-O-methyl-RNA/DNA oligonucleotide
was annealed from position 123 to 133 upstream from the 3'-end of the
151-nt RNA. After the RNase H cleavage, the ternary complex containing
a 122-nt RNA remained as active as a mock-cleaved control complex (data
not shown).
To sample more complexes containing different lengths of RNA after the
RNase H cleavage reaction, we repeated the above experiments on
complexes G157 and A160. The sequences of these RNAs are shown in Fig.
1, and results are summarized in Fig. 5. A clear trend could be
discerned from these tests. If the RNA in the ternary complex after
cleavage was longer than about 20 nt and shorter than about 50 nt, the
complex was prone to arrest. However, complexes with shorter or longer
RNAs were as elongation-competent as noncleaved controls.
Promoter-proximal Complexes--
As noted above, other work in our
laboratory has shown that RNA polymerase II complexes stalled from 20 to 32 nt downstream of the transcription start on the pML20-23like
template are arrested to a significant extent (16). In order to
quantitatively compare the elongation competence of promoter-proximal
and promoter-distal complexes in the pML20-23 sequence context, it was
necessary to subject the promoter-proximal complexes to the same
extensive 37 °C incubations used in RNase H digestion of the
promoter-distal complexes. Fig. 4 shows a
representative experiment of this type with the pML20-23like3
template. The first position on this template where the polymerase
complex can be stalled by NTP limitation is +17. Complex G17 was
synthesized and body-labeled with radioactive GTP. After sarkosyl
rinsing, this complex could be advanced to C18 by the addition of CTP.
The G17 and C18 complexes were further incubated at 37 °C for 10 min
(in the absence of RNase H) to treat them identically to the RNase
H-cleaved samples (lanes 4-9). A subsequent
chase with all four NTPs was carried out in the presence or absence of
the transcription elongation factor SII. We found that both G17 and C18
were fully active under these conditions, since only 2% of the
complexes could not be chased (see lanes 5 and
8). However, we obtained a very different result when we assayed complexes with longer nascent RNAs. Complex C23 was synthesized with radioactive CTP, so that all of the label was incorporated in the
3'-most 6 nt of this RNA (see Fig. 1). After sarkosyl rinsing, C23 was
extended to U26, G29, or A32 by the addition of the corresponding nonlabeled NTPs at 25 °C for 5 min. All complexes were incubated at
37 °C for 10 min and then chased with all four NTPs at 37 °C for
5 min. All of the complexes with 23-32-nt RNAs were found to be
severely arrested in this assay (lanes 11,
14, 17, and 20). Inclusion of SII in
the chase reaction resulted in the disappearance of all of the
23-32-mer RNAs and the appearance of labeled cleavage products of
about 10-20 nt (lanes 12, 15,
18, and 21). Almost no labeled run-off RNA was
made in these SII-containing chase reactions, since all of the label in
the initial ternary complex RNAs was released by transcript cleavage
and subsequent elongation took place with nonlabeled NTPs. We did
confirm with uniformly labeled C23-A32 RNA that the transcript that
remained in the ternary complex was fully extended to run-off during
chase in the presence of SII (data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Elongation competence of promoter-proximal
complexes. Transcripts were synthesized from preinitiation
complexes on the pML20-23like3 template as described under
"Materials and Methods." The initial transcribed sequence of this
plasmid is shown at the bottom. Lanes
1-9, Sarkosyl-rinsed complexes containing GTP-labeled G17
RNA (lane 1) were incubated at 25 °C for 5 min
with (lane 3) or without (lane
2) CTP to allow advance to +18. These G17 (lanes
4-6) and C18 (lanes 7-9) complexes
were incubated for an additional 10 min at 37 °C to mimic the
conditions of the RNase H digestion used in Figs. 2 and 3 and were then
immediately chased with all four NTPs (lanes 5 and 8); SII was included in the chase in lanes
6 and 9. Complex C23 was generated from
preinitiation complex with radioactive CTP, followed by Sarkosyl
rinsing, as described under "Materials and Methods"
(lanes 10-12). These C23 complexes were
elongated to U26 (lanes 13-15), G29
(lanes 16-18) or A32 (lanes
19-21) by limited (nonlabeled) nucleotide addition at
25 °C for 5 min and were further incubated at 37 °C for 10 min.
Chase with all four NTPs in the presence or absence of SII immediately
followed at 37 °C for 5 min. SII cleavage products (3'-end of the
cleaved RNA) can be seen in lanes 12,
15, 18, and 21. The percentage of arrest for each
ternary complex is indicated in the top
line.
|
|
The data on the elongation competence of halted pML20-23like3
complexes are summarized in Fig. 5. There
was a very close correspondence in arrest levels for the
promoter-proximal and promoter-distal complexes with identical
transcript lengths. Those complexes with RNAs shorter than about 20 nt
were active, whereas complexes with 20-32-nt RNAs were predominantly
arrested. We did not attempt to study promoter-proximal complexes
containing RNAs longer than 32 nt with the techniques used here, since
all possible precursor complexes, from C23 to A32, are highly
arrested.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison of the extent of arrest in
promoter-proximal and promoter-distal complexes. The fraction of
complexes which failed to chase, determined as shown in Figs. 2-4, is
given for promoter-proximal complexes on the pML20-23like3 template
(black bars) and promoter-distal complexes on the
pML20-23 template whose transcripts were truncated by
oligonucleotide-directed RNase H cleavage (gray
bars). The averages of two or three independent experiments,
with S.D. values as error bars, are reported.
|
|
Hybridization of Oligonucleotides to Upstream Segments of the
Transcript Can Lead to Arrest--
Transcriptional arrest by RNA
polymerase II, at least in promoter-distal complexes, appears to be
invariably accompanied by upstream translocation of the RNA polymerase.
Thus, if the upstream segment of the transcript has an anti-arrest
effect, one might expect this effect to be based on the prevention of
upstream translocation, for example by direct interaction with the RNA
polymerase or by the formation of secondary structure. This model
predicts that interfering with the blockade of upstream translocation
could lead to arrest. To test this idea, we hybridized oligonucleotides to the nascent RNA over segments ranging from 19 to 59 nt upstream of
the point of bond formation. We reasoned that if interactions or
structures important in arrest prevention must form over this region,
oligonucleotide hybridization should compete with or prevent these
interactions. For this test, we used the C151 complexes and the
chimeric oligonucleotides previously discussed as well as an additional
oligonucleotide, chimera 5, complementary to a segment 31-42 nt
upstream of the 3'-end of the RNA. The oligonucleotides were incubated
with the complexes at 37 °C for 10 min as before but in the absence
of RNase H. After the incubation, reactions were chased with excess
NTPs. Hybridization with chimera 2 actually reduced arrest (Fig.
6A; compare
lane 1 with lane 2 and
lane 3 with lane 4), as
expected from earlier studies (31). However, incubation with chimeras
1, 5, and 3 caused partial arrest of complex C151 (37, 42, and 35%,
respectively). This arrest could be relieved by the addition of SII
(data not shown). To demonstrate that all of the chimeras did hybridize
to the transcript, we treated aliquots of the hybridization reactions
with RNase H. In all cases, the expected cleavage was observed
(lanes 5, 8, 11, and
14).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 6.
Induction of arrest by hybridization of
oligonucleotides to the nascent RNA. A, the indicated
chimeras were annealed to body-labeled C151 RNA (see Fig. 1) at
37 °C for 10 min. RNase H was also added in the indicated lanes, to
verify proper annealing of the oligonucleotides. In the indicated
lanes, transcripts were chased by the addition of 50 µM GTP, ATP, and
CTP at 37 °C for 10 min. The sizes of the bands are indicated to the
right. B, summary of the effects of hybridization
on complexes C151 and U154. The complementary positions of the chimeras
to the RNA are indicated. Each chimera annealed 3 nt more distal from
the 3'-end of the RNA on the U154 complexes as compared with C151. The
values for percentage arrest were corrected by subtraction of the
percentage arrest observed in the absence of the chimeras. S.D. values
were calculated from 2-5 independent experiments.
|
|
We have repeated this experiment several times with both complexes C151
and U154. The results are summarized in Fig. 6B. The percentage arrest values were normalized to the background that is
measured in the absence of the chimeras. Arrest above background was
seen with oligonucleotides hybridizing from 24 to 45 nt upstream of the
3'-end. The greatest effect was observed with chimera 1 and the U154
complex, where the oligonucleotide hybrid extended from 27 to 36 nt
upstream. Hybridization to locations more than 46 nt upstream did not
significantly diminish elongation competence. This is consistent with
our observation (Fig. 5) that complete elongation competence requires a
transcript at least 51 nt long.
We hypothesized that arrest from oligonucleotide hybridization results
from interfering with a mechanism that would otherwise block upstream
translocation by the RNA polymerase. It was therefore important to
demonstrate directly that the arrest seen in Fig. 6 did result from
upstream translocation. To do this, we produced U154 complexes labeled
only in the last 3 nt and incubated these complexes with chimeric
oligonucleotide 1, 2, 3, or 5 (or with no oligonucleotide, as
control). The complexes were then treated with SII (Fig.
7). Mock-hybridized complexes
(lanes 3 and 4), which were mostly
elongation-competent (see Fig. 6), gave predominantly short SII
cleavage products as expected (32, 33). The longer (about 6-13 nt) SII
cleavage products in lane 4 presumably arose from
the low level of arrested complexes. Hybridization with chimera 2, which did not reduce transcriptional competence in the experiment in
Fig. 6, did not substantially change the partitioning of SII cleavage
fragments as compared with the mock hybridization control. However,
significant increases in the proportion of large SII cleavage products
and coordinate diminution of short cleavage products was seen after
hybridization with chimera 5 and particularly with chimera 1;
the latter oligonucleotide was the most effective in inducing
arrest in the Fig. 6 assay. Thus, the induction of arrest
through oligonucleotide hybridization is accompanied by upstream
translocation by the RNA polymerase.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
Hybridization of oligonucleotides well
upstream of the RNA 3'-end causes upstream
translocation of polymerase II. Complex U154 was synthesized on
plasmid pML20-23 (lanes 3-12). The indicated
chimeras were annealed to the 3'-end-labeled RNA at 37 °C for 5 min.
The complementary positions of the chimeras to the RNA are shown in
Figs. 1 and 6. Incubation was continued at 37 °C for 5 min in the
absence or presence of SII as indicated above the
lanes. The fraction of total cleavage products that were
long (about 6-15 nt) or short (primarily dinucleotides) was determined
and is indicated at the top. The location of these cleavage
products is indicated to the left. RNA length markers of 17 (lane 14) or 23 (lane 1) nt
were generated on plasmid pML20-23like3; the marker reactions in
lanes 2 and 13 were treated with SII
before purification of the RNAs (see Ref. 16).
|
|
Transcript Truncation Causes Reduced Elongation Competence in
Another, Completely Different Sequence Context--
To eliminate the
possibility that the effects we have observed are somehow specific to
the purine-rich initially transcribed sequence of pML20-23like3, we
have also repeated our basic experiment using a template with a
completely different initially transcribed sequence. In our earlier
work, we studied adenovirus major late promoter-based templates, such
as pML20-42, which have pyrimidine-rich initially transcribed regions.
RNA polymerases halted in promoter-proximal locations on these
templates generally show much lower levels of arrest than we observed
for polymerases stalled in the promoter-proximal region of the
pML20-23like plasmids (16). A partial exception to this rule was
provided by complexes stalled at +23 on pML20-42; about 40% of these
polymerases could not extend their RNA chains after a 5-min chase under
the conditions of our original study (16). We therefore constructed a
new template, designated pML20-55 M, which is diagrammed in Fig.
8A. On this template, RNA
synthesis will proceed to +23 when preinitiation complexes are
incubated with CpA, CTP, UTP, and ATP. After sarkosyl rinsing, the
complexes may be advanced to +54 in an ATP-less reaction, rinsed under
native conditions, and then walked to +77 with CTP, ATP, and UTP. Note that treatment of complexes stalled at +77 with RNase T1 will result in
truncation of the RNAs in the complex to 24-mers, which are identical
to the RNAs present in CpA-primed, promoter-proximal complexes stalled
at +23 (Fig. 8A, underlined
sequences). When the initial, CpA-primed transcription
reaction on pML20-55 M included radiolabled CTP, we could observe the
resulting A24 complexes (Fig. 8B, lanes
1-4). Exposure of these complexes to mock T1 digestion (incubation at 37 °C for 5 min) before chase resulted in a somewhat greater level of arrest than we had seen in our earlier study (16). In
the example shown in Fig. 8B, 67% of the A24 complexes became arrested (compare lanes 1 and
2). When polymerases were walked to +77 on the pML20-55 M
template, [32P]CTP was only included in the final step so
that only the final 23 nt were labeled. The resulting A78 complexes
showed a much lower level of arrest after exposure to the mock T1
digestion at 37 °C, as compared with the promoter-proximal A24
complexes. For the experiment shown in Fig. 8B, 22% of the
A78 complexes were arrested after mock digestion (compare
lanes 9 and 10; note from
lane 12 that all of the complexes resumed
transcription when SII was added). Treatment of the A78 complexes with
RNase T1 for 5 min at 37 °C cleaved essentially all of the RNA to
give the collection of bands shown in lane 5 of
Fig. 8B. When these complexes were chased, 67% of the A24
RNAs could not advance in the absence of SII (lane
6), whereas all of the RNAs were elongated with SII (lane 8). Thus, as we observed in the experiments
shown in Figs. 2 and 3, promoter-distal complexes whose transcripts are
truncated have the elongation competence of the corresponding
promoter-proximal complex bearing RNA of the same length and
sequence.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 8.
Truncation of the transcript in a second
sequence context also leads to greatly increased transcriptional
arrest. A, sequence of the initially transcribed region
(nontemplate strand) of the pML20-55 M template. The identical
promoter-proximal and promoter-distal sequences are
underlined. The positions downstream of +1 at which the
polymerase was stalled are indicated. B, preinitiation
complexes formed on bead-attached, PCR-generated pML20-55 M linear
templates were incubated with CpA (which pairs with the template at
positions 1/+1), [ -32P]CTP, UTP, and ATP to obtain
complexes stalled at +23. These promoter-proximal A24 complexes were
rinsed with sarkosyl prior to testing for the elongation competence
(lanes 1-4). A78 complexes (the precursors for
promoter-distal A24 complexes) were generated by incubating
preinitiation complexes with the same set of NTPs used for generating
the promoter-proximal A24 complexes except that the CTP was not
radiolabeled. After rinsing with Sarkosyl, the nonlabled A24 complexes
were walked to +54 with CTP, GTP, and UTP, rinsed with transcription
buffer to remove free NTPs, and then advanced to +77 with
[ -32P]CTP, UTP, and ATP. The promoter-distal A24
complexes were obtained by digesting A78 complexes with RNase T1 (10 units of T1 in a 10-µl reaction for 5 min at 37 °C) to liberate
the upstream segment of the transcript (the 3'-most T1 cleavage site is
indicated by the arrow in A). The T1-treated
complexes were washed with transcription buffer to remove liberated
RNAs and RNase T1. All complexes were tested under identical conditions
for elongation competence (30 °C for 10 min with a 200 µM concentration of all four NTPs) with or without SII
(at a final concentration of 29 µg/ml) as indicated. The A78
complexes and the promoter-proximal A24 complexes were mock-treated
without RNase T1 at 37 °C for 5 min before chase.
|
|
 |
DISCUSSION |
RNA polymerase II complexes paused in promoter-proximal locations
have a strong tendency to translocate upstream (16, 26), an event that
in many cases results in transcriptional arrest. This is an unexpected
finding, because the promoter-proximal sequences in question do not
cause arrest when traversed by the polymerase far downstream of
transcription start. In this paper, we show directly that this unusual
property of promoter-proximal RNA polymerase II complexes may be
recreated simply by shortening the nascent RNA within complexes that
had transcribed to a promoter-distal location. We conclude that the
transition to full elongation competence by RNA polymerase II is
dependent on the synthesis of about 50 nt of RNA. Interestingly, this
transition appears to be reversible.
Current Models for Transcript Elongation Complexes Do Not Predict
Our Results--
A basic model for the transcript elongation complex
assigns the major role in complex stability to two features: the
RNA-DNA hybrid (most frequently thought to be about 8-9 bp long) and
the interaction of a segment of the polymerase (the sliding clamp) with
DNA immediately downstream of the point of bond formation (reviewed in
Refs. 2 and 34). The large body of work that supports this model
involves a number of different experimental approaches with both
E. coli RNA polymerase and RNA polymerase II (31, 35-40).
Whereas some of these studies have differed on the length of the
RNA-DNA hybrid needed to confer maximal stability and the relative
importance of the hybrid and the sliding clamp, the two basic features
of this model explain most recent observations.
A major finding of the current work is that this "hybrid plus sliding
clamp" model does not predict the behavior of RNA polymerase II
complexes containing RNAs of less than 50 nt. It is important to stress
that the sequence context we chose for most of our study (all
experiments except for those in Fig. 8) had been shown to provide no
barriers to transcription in a promoter-distal location. RNA
polymerases stalled within this region remained transcriptionally active and did not show upstream translocated footprints (10). One
would therefore predict that polymerases halted in this local sequence
context have neither unfavorable interactions with downstream DNA nor
particularly weak RNA-DNA hybrids. In reference to the latter point, it
is worth noting that many of the complexes we studied have transcripts
with GC-rich 3'-ends. For example, the C23 complex (Fig. 4) and the
corresponding C151 complex trimmed back to C23 (Fig. 2) were both
severely arrested, yet both complexes should contain RNA-DNA hybrids in
which six of the eight base pairs, including the four base pairs at the
3'-end, are CG or GC (see Fig. 1).
Our results indicate that in addition to the RNA-DNA hybrid and the
sliding clamp, far upstream nascent RNA is also an important feature in
stabilizing the transcript elongation complex along the DNA template.
Many earlier studies have demonstrated that the multisubunit RNA
polymerases protect from 14 to 18 nt of RNA upstream of the point of
bond formation from nuclease attack (36, 41, 42). Using E. coli RNA polymerase and a synthetic bubble template, Wilson
et al. (43) showed that extension of the transcript from 12 to 20 nt is important in stabilizing the elongation complex. The
crystal structure of the yeast RNA polymerase II ternary complex (7)
reveals a likely RNA exit channel that could accommodate about 10 nt
upstream of the 8-9-bp RNA-DNA hybrid. However, there are no data on
the path of the RNA beyond about 20 nt upstream of the active site.
Thus, none of these earlier results would have predicted that
transcription complexes that do not have a very weak RNA-DNA hybrid
would be strongly affected by the transcript segment from 20 to 50 nt upstream.
A recently reported observation does address a potential functional
role for far upstream RNA sequences. Kireeva et al. (44) studied yeast RNA polymerase II transcription complexes that were directly assembled from purified polymerase, synthetic template, and
nontemplate strands and 9-nt RNA primers. RNA polymerase recognizes and
extends the preformed RNA-DNA hybrid in this system. These complexes
strongly resemble promoter-initiated complexes by a number of assays.
Significantly, halted yeast RNA polymerase II complexes bearing 9- or
40-nt transcripts were much more likely to resume transcription than
complexes containing 20, 23, or 34 nt RNAs when challenged with a 1 µM concentration of the next NTP to be added. Thus, yeast
RNA polymerase II also seems to have a transient phase early in
transcript elongation during which halting the RNA polymerase leaves
the enzyme in danger of not being able to resume transcription.
The Transition by RNA Polymerase II from Initiation to
Elongation--
We had previously suggested (16, 25) that the
acquisition of lateral stability on the template, between roughly
positions +20 and +50, is the last step in the commitment of RNA
polymerase II to the transcript elongation phase of RNA synthesis.
Among the changes that such a transition could reflect are the complete closure of the clamp structure that constrains the template within the
ternary complex (7) and the formation of a transcription bubble with
the dimensions characteristic of the elongation-committed polymerase
(45). The net effect of these events presumably locks the polymerase in
the stable elongation configuration. Whereas such changes may indeed be
characteristic of the initiation-elongation transition, the somewhat
surprising finding from the present study is that these
changes are reversible. The response of the transcription complex to a
particular length and sequence of transcript is essentially the same,
regardless of whether that complex had previously passed through the
initiation-elongation transition (Fig. 5).
A major unanswered question from our work concerns the molecular basis
for the strong tendency of RNA polymerase II complexes with between 20 and 50 nt of nascent RNA to translocate upstream. What destabilizing
effect makes the stabilizing influence of upstream RNA necessary? We
speculate that once the nascent RNA reaches a critical length (which
would be about 20 nt in the sequence context of the pML20-23like3
template), there is a transient negative interaction of the RNA with
the polymerase. Translocating upstream to avoid this interaction would
cause arrest.
How Does Upstream RNA Function to Prevent Arrest?--
It is well
established that base pairing of the transcript either with itself or
with DNA oligonucleotides can prevent reverse threading of the RNA and
thus block arrest (31). Interference with secondary structure in the
transcript could account for the results of our oligonucleotide
hybridizations in Fig. 6. It is possible that promoter-distal complexes
such as U154 are normally stabilized against lateral movement on the
template by transcript secondary structure extending up to the point at
which the transcript emerges from the polymerase. Hybridization with,
for example, chimera 1 would replace the polymerase-proximal secondary
structure with a chimeric oligonucleotide-transcript hybrid extending
from 27 to 36 nt upstream of the 3'-end. This would leave 8-9 nt of unpaired RNA between the polymerase and the chimera hybrid (41), thus
allowing reverse threading of the transcript and upstream translocation
by the polymerase. If the hybrid between the oligonucleotide and the
transcript were located far enough upstream, the RNA between the
polymerase and the oligonucleotide hybrid could reform secondary structure either by pairing with itself or with far-upstream transcript sequences. Hybridization of oligos upstream of this location (see, for
example, the results with chimera 3 in Fig. 6B) would no
longer provoke significant arrest.
It is important to stress that the role of the transcript in preserving
elongation competence must extend beyond the simple formation of
secondary structure. This point can be most easily made by considering
successive complexes in early elongation that do or do not display
upstream translocation when stalled. For example, the A32 complex (Fig.
4) is predominantly arrested and upstream-translocated (16); however,
the C35 complex on the same template is neither upstream-translocated
nor arrested. When RNA polymerase reaches position +35, the sequence of
the RNA that has emerged from the polymerase should be
5'-ACAGGAAGAGGAAGAAGC (assuming that 17 nt upstream of the 3'-end
remain protected by the polymerase; see Ref. 41). There is no apparent
opportunity for secondary structure to form within this RNA. Similarly,
whereas the G25 complex on the pML20-42 template is
upstream-translocated, the C27 complex on the same template occupies
the normal template position for elongation-competent complexes (26).
In the case of the C27 complex, the RNA external to the polymerase
should have the sequence 5'-ACUCUCUUCC; again, one would not predict any secondary structure for this RNA.
Since the nascent transcript is probably not acting to stabilize early
elongation complexes by forming secondary structure, a potential
alternative mechanism would involve interaction of the RNA with
some protein component of the transcription complex. In this
context, it is interesting to recall the results of Milan et
al. (42), who observed that treatment of E. coli RNA
polymerase complexes with low levels of RNase T1 revealed partial
protection over the initial 15-16 nt upstream from the 3' RNA terminus
and over a second region from 30 to 45 nt upstream. This finding, in
conjunction with the reported high level of structural similarity between the bacterial and eukaryotic RNA polymerases (46, 47), suggests
the possibility that RNA polymerase II complexes might be stabilized by
the direct interaction of the transcript and the polymerase at roughly
30-45 bases upstream of the 3'-end of the RNA.
The Significance of the Distinctive Properties of RNA Polymerase II
Complexes with 20-50-nt Nascent RNAs--
Finally, it is important to
recall that in those genes in which the transition to elongation is
regulated, stalled RNA polymerases are typically found 20-50 nt
downstream of transcription start (e.g. between +21 and +35
on the Drosophila hsp70 gene (reviewed in Ref.
19) and at about +45 on the human hsp70 gene (23)). We
propose that the cell exploits the tendency of promoter-proximal RNA
polymerases to arrest in order to provide an opportunity for negatively
acting transcription factors to interact with the enzyme. The concerted
action of negatively and positively acting transcription factors
could then regulate the transition into productive transcript elongation (48-51).
 |
ACKNOWLEDGEMENTS |
We thank Robert Landick for stimulating
discussions and David McKean for advice during the course of these experiments.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM-29487.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Biology, Mail Location NC20, Cleveland Clinic Foundation, 9500 Euclid
Ave., Cleveland, OH 44195. Tel.: 216-445-7688; Fax: 216-444-0512; E-mail: lused@ccf.org.
Published, JBC Papers in Press, June 26, 2002, DOI 10.1074/jbc.M201145200
 |
ABBREVIATIONS |
The abbreviation used is:
nt, nucleotide(s).
 |
REFERENCES |
| 1.
|
Uptain, S. M.,
Kane, C. M.,
and Chamberlin, M. J.
(1997)
Annu. Rev. Biochem.
66,
117-172[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Landick, R.
(1997)
Cell
88,
741-744[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Cramer, P.,
Bushnell, D. A., Fu, J. H.,
Gnatt, A. L.,
Maier-Davis, B.,
Thompson, N. E.,
Burgess, R. R.,
Edwards, A. M.,
David, P. R.,
and Kornberg, R. D.
(2000)
Science
288,
640-649[Abstract/Free Full Text]
|
| 4.
|
Zhang, G. Y.,
Campbell, E. A.,
Minakhin, L.,
Richter, C.,
Severinov, K.,
and Darst, S. A.
(1999)
Cell
98,
811-824[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Naryshkin, N.,
Revyakin, A.,
Kim, Y. G.,
Mekler, V.,
and Ebright, R. H.
(2000)
Cell
101,
601-611[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Korzheva, N.,
Mustaev, A.,
Kozlov, M.,
Malhotra, A.,
Nikiforov, V.,
Goldfarb, A.,
and Darst, S. A.
(2000)
Science
289,
619-625[Abstract/Free Full Text]
|
| 7.
|
Gnatt, A. L.,
Cramer, P., Fu, J.,
Bushnell, D. A.,
and Kornberg, R. D.
(2001)
Science
292,
1876-1882[Abstract/Free Full Text]
|
| 8.
|
Kerppola, T. K.,
and Kane, C. M.
(1990)
Biochemistry
29,
269-278[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Gu, W.,
Powell, W.,
Mote, J., Jr.,
and Reines, D.
(1993)
J. Biol. Chem.
268,
25604-25616[Abstract/Free Full Text]
|
| 10.
|
Samkurashvili, I.,
and Luse, D. S.
(1996)
J. Biol. Chem.
271,
23495-23505[Abstract/Free Full Text]
|
| 11.
|
Izban, M. G.,
and Luse, D. S.
(1992)
Genes Dev.
6,
1342-1356[Abstract/Free Full Text]
|
| 12.
|
Reines, D.,
Ghanouni, P., Li, Q. Q.,
and Mote, J.
(1992)
J. Biol. Chem.
267,
15516-15522[Abstract/Free Full Text]
|
| 13.
|
Rudd, M. D.,
Izban, M. G.,
and Luse, D. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8057-8061[Abstract/Free Full Text]
|
| 14.
|
Borukhov, S.,
Sagitov, V.,
and Goldfarb, A.
(1993)
Cell
72,
459-466[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Orlova, M.,
Newlands, J.,
Das, A.,
Goldfarb, A.,
and Borukhov, S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4596-4600[Abstract/Free Full Text]
|
| 16.
|
Pal, M.,
McKean, D.,
and Luse, D. S.
(2001)
Mol. Cell. Biol.
21,
5815-5825[Abstract/Free Full Text]
|
| 17.
|
Nudler, E.,
Goldfarb, A.,
and Kashlev, M.
(1994)
Science
265,
793-796[Abstract/Free Full Text]
|
| 18.
|
Komissarova, N.,
and Kashlev, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1755-1760[Abstract/Free Full Text]
|
| 19.
|
Lis, J.
(1998)
Cold Spring Harbor Symp. Quant. Biol.
63,
347-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Krumm, A.,
Meulia, T.,
Brunvand, M.,
and Groudine, M.
(1992)
Genes Dev.
6,
2201-2213[Abstract/Free Full Text]
|
| 21.
|
Strobl, L. J.,
and Eick, D.
(1992)
EMBO J.
11,
3307-3314[Medline]
[Order article via Infotrieve]
|
| 22.
|
Plet, A.,
Eick, D.,
and Blanchard, J. M.
(1995)
Oncogene
10,
319-328[Medline]
[Order article via Infotrieve]
|
| 23.
|
Brown, S. A.,
Imbalzano, A. N.,
and Kingston, R. E.
(1996)
Genes Dev.
10,
1479-1490[Abstract/Free Full Text]
|
| 24.
|
Laspia, M. F.,
Wendel, P.,
and Mathews, M. B.
(1993)
J. Mol. Biol.
232,
732-746[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Luse, D. S.,
and Samkurashvili, I.
(1998)
Cold Spring Harbor Symp. Quant. Biol.
63,
289-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Samkurashvili, I.,
and Luse, D. S.
(1998)
Mol. Cell. Biol.
18,
5343-5354[Abstract/Free Full Text]
|
| 27.
|
Yoo, O.,
Yoon, H.,
Baek, K.,
Jeon, C.,
Miyamoto, K.,
Ueno, A.,
and Agarwal, K.
(1991)
Nucleic Acids Res.
19,
1073-1079[Abstract/Free Full Text]
|
| 28.
|
Lapham, J.,
and Crothers, D. M.
(1996)
RNA
2,
289-296[Abstract]
|
| 29.
|
Lapham, J., Yu, Y. T.,
Shu, M. D.,
Steitz, J. A.,
and Crothers, D. M.
(1997)
RNA
3,
950-951[Medline]
[Order article via Infotrieve]
|
| 30.
|
Hawley, D. K.,
and Roeder, R. G.
(1987)
J. Biol. Chem.
262,
3452-3461[Abstract/Free Full Text]
|
| 31.
|
Reeder, T. C.,
and Hawley, D. K.
(1996)
Cell
87,
767-777[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Izban, M. G.,
and Luse, D. S.
(1993)
J. Biol. Chem.
268,
12874-12885[Abstract/Free Full Text]
|
| 33.
|
Izban, M. G.,
and Luse, D. S.
(1993)
J. Biol. Chem.
268,
12864-12873[Abstract/Free Full Text]
|
| 34.
|
Nudler, E.
(1999)
J. Mol. Biol.
288,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Kireeva, M. L.,
Komissarova, N.,
Waugh, D. S.,
and Kashlev, M.
(2000)
J. Biol. Chem.
275,
6530-6536[Abstract/Free Full Text]
|
| 36.
|
Komissarova, N.,
and Kashlev, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14699-14704[Abstract/Free Full Text]
|
| 37.
|
Sidorenkov, I.,
Komissarova, N.,
and Kashlev, M.
(1998)
Mol. Cell
2,
55-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Nudler, E.,
Gusarov, I.,
Avetissova, E.,
Kozlov, M.,
and Goldfarb, A.
(1998)
Science
281,
424-428[Abstract/Free Full Text]
|
| 39.
|
Nudler, E.,
Mustaev, A.,
Lukhtanov, E.,
and Goldfarb, A.
(1997)
Cell
89,
33-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Nudler, E.,
Avetissova, E.,
Markovtsov, V.,
and Goldfarb, A.
(1996)
Science
273,
211-217[Abstract]
|
| 41.
|
Gu, W. G.,
Wind, M.,
and Reines, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6935-6940[Abstract/Free Full Text]
|
| 42.
|
Milan, S.,
D'Ari, L.,
and Chamberlin, M. J.
(1999)
Biochemistry
38,
218-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Wilson, K. S.,
Conant, C. R.,
and von Hippel, P. H.
(1999)
J. Mol. Biol.
289,
1179-1194[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Kireeva, M. L.,
Komissarova, N.,
and Kashlev, M.
(2000)
J. Mol. Biol.
299,
325-335[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Fiedler, U.,
and Timmers, H. T. M.
(2001)
Nucleic Acids Res.
29,
2706-2714[Abstract/Free Full Text]
|
| 46.
|
Ebright, R. H.
(2000)
J. Mol. Biol.
304,
687-698[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Cramer, P.,
Bushnell, D. A.,
and Kornberg, R. D.
(2001)
Science
292,
1863-1876[Abstract/Free Full Text]
|
| 48.
|
Wada, T.,
Orphanides, G.,
Hasegawa, J.,
Kim, D. K.,
Shima, D.,
Yamaguchi, Y.,
Fukuda, A.,
Hisatake, K., Oh, S.,
Reinberg, D.,
and Handa, H.
(2000)
Mol. Cell
5,
1067-1072[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Kaplan, C. D.,
Morris, J. R., Wu, C. T.,
and Winston, F.
(2000)
Genes Dev.
14,
2623-2634[Abstract/Free Full Text]
|
| 50.
|
Andrulis, E. D.,
Guzmán, E.,
Döring, P.,
Werner, J.,
and Lis, J. T.
(2000)
Genes Dev.
14,
2635-2649[Abstract/Free Full Text]
|
| 51.
|
Lis, J. T.,
Mason, P.,
Peng, J.,
Price, D. H.,
and Werner, J.
(2000)
Genes Dev.
14,
792-803[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Cheng and D. H. Price
Analysis of factor interactions with RNA polymerase II elongation complexes using a new electrophoretic mobility shift assay
Nucleic Acids Res.,
November 1, 2008;
36(20):
e135 - e135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Core and J. T. Lis
Transcription Regulation Through Promoter-Proximal Pausing of RNA Polymerase II
Science,
March 28, 2008;
319(5871):
1791 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. West and N. J. Proudfoot
Human Pcf11 enhances degradation of RNA polymerase II-associated nascent RNA and transcriptional termination
Nucleic Acids Res.,
February 11, 2008;
36(3):
905 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Andrecka, R. Lewis, F. Bruckner, E. Lehmann, P. Cramer, and J. Michaelis
Single-molecule tracking of mRNA exiting from RNA polymerase II
PNAS,
January 8, 2008;
105(1):
135 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gromak, S. West, and N. J. Proudfoot
Pause Sites Promote Transcriptional Termination of Mammalian RNA Polymerase II
Mol. Cell. Biol.,
May 15, 2006;
26(10):
3986 - 3996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rosonina, S. Kaneko, and J. L. Manley
Terminating the transcript: breaking up is hard to do.
Genes & Dev.,
May 1, 2006;
20(9):
1050 - 1056.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. R. Tadigotla, D. O Maoileidigh, A. M. Sengupta, V. Epshtein, R. H. Ebright, E. Nudler, and A. E. Ruckenstein
Thermodynamic and kinetic modeling of transcriptional pausing
PNAS,
March 21, 2006;
103(12):
4439 - 4444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Palangat, D. B. Renner, D. H. Price, and R. Landick
A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS
PNAS,
October 18, 2005;
102(42):
15036 - 15041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Prather, E. Larschan, and F. Winston
Evidence that the Elongation Factor TFIIS Plays a Role in Transcription Initiation at GAL1 in Saccharomyces cerevisiae
Mol. Cell. Biol.,
April 1, 2005;
25(7):
2650 - 2659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ujvari and D. S. Luse
Newly Initiated RNA Encounters a Factor Involved in Splicing Immediately upon Emerging from within RNA Polymerase II
J. Biol. Chem.,
November 26, 2004;
279(48):
49773 - 49779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Malagon, A. H. Tong, B. K. Shafer, and J. N. Strathern
Genetic Interactions of DST1 in Saccharomyces cerevisiae Suggest a Role of TFIIS in the Initiation-Elongation Transition
Genetics,
March 1, 2004;
166(3):
1215 - 1227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pal and D. S. Luse
The initiation-elongation transition: Lateral mobility of RNA in RNA polymerase II complexes is greatly reduced at +8/+9 and absent by +23
PNAS,
May 13, 2003;
100(10):
5700 - 5705.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|